Fortune or foresight? AstraZeneca and Oxford’s stories clash on COVID-19 vaccine
London (Reuters) – AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing
Read MoreLondon (Reuters) – AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing
Read MoreZURICH (Reuters) – The promise of COVID-19 vaccines is “phenomenal” and “potentially game-changing”, World Health Organization European director Hans Kluge
Read MoreLondon (Reuters) – Britain approved Pfizer’s COVID-19 vaccine on Wednesday, jumping ahead of the rest of the world in the
Read MoreGeneva (Reuters) – This year is on track to be the second hottest on record, behind 2016, the World Meteorological
Read MoreBeijing (Reuters) – China successfully landed a spacecraft on the moon’s surface on Tuesday in a historic mission to retrieve
Read MoreTel Aviv – An Israeli company is in the final-stages of testing its oral insulin tablets which will replace injections.
Read MoreReuters The frontrunners in the COVID-19 vaccine race have emerged with different success rates for their shots in clinical trials,
Read MoreLondon (Reuters) – Days after grabbing headlines with its COVID-19 “vaccine for the world”, AstraZeneca is facing tricky questions about
Read Moreby Ashley Rosa Past studies have shown that exercise has a positive effect on a person’s mood. A study containing
Read MoreBrasilia (Reuters) – Vaccinating 20% of the population of Latin America and the Caribbean against COVID-19 will cost more than
Read More